Concepedia
Statistics
Publications
10
Citations
385
H-Index
Active since
2016
Affiliations
Semmelweis University(Current)
Hungarian Academy of Sciences
HUN-REN Institute of Experimental Medicine
University of Copenhagen
Nordic Bioscience (Denmark)
Dóra Balogh is an author at Semmelweis University specializing in medicine, pharmacology, and endocrinology.
Top concepts
MedicinePharmacologyEndocrinologyDiabetesImmunologyPhysiologyInflammationNeuroscienceNeuroprotectionSocial Sciences
Publications per year
2016–2024
RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition
Sándor Kőszegi, Ágnes Molnár, Lilla Lénárt et al. · The Journal of Physiology · 2018 · 87 citations · Full text
σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury
Ádám Hosszú, Zsuzsanna Antal, Lilla Lénárt et al. · Journal of the American Society of Nephrology · 2016 · 59 citations · Full text
Immunology, Renal Inflammation, Cellular Physiology +21
Reduced <i>O</i>-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney
Judit Hodrea, Dóra Balogh, Ádám Hosszú et al. · American Journal of Physiology-Renal Physiology · 2020 · 51 citations · Full text
Role of<i>O</i>-linked<i>N</i>-acetylglucosamine modification in diabetic nephropathy
Renáta Gellai, Judit Hodrea, Lilla Lénárt et al. · American Journal of Physiology-Renal Physiology · 2016 · 50 citations · Full text
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes
Judit Hodrea, Adar Saeed, Ágnes Molnár et al. · PLoS ONE · 2022 · 34 citations · Full text
1–5 of 10